{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:43:16Z","timestamp":1776400996838,"version":"3.51.2"},"reference-count":56,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,28]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>High-throughput sequencing of primary African Burkitt lymphoma tumors suggests disrupted immunoglobulin rearrangements in BL progenitors. Extensive mutation of expressed and nonexpressed IGH rearrangements suggests multiple active mutational processes in BL tumors.<\/jats:p>","DOI":"10.1182\/bloodadvances.2016000794","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T20:47:15Z","timestamp":1490129235000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis"],"prefix":"10.1182","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-5669","authenticated-orcid":false,"given":"Katharine A.","family":"Lombardo","sequence":"first","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Molecular and Cellular Biology Program and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-8836","authenticated-orcid":false,"given":"David G.","family":"Coffey","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine, School of Medicine, University of Washington, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia J.","family":"Morales","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-3538","authenticated-orcid":false,"given":"Christopher S.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M. H.","family":"Towlerton","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Gerdts","sequence":"additional","affiliation":[{"name":"Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis K.","family":"Nkrumah","sequence":"additional","affiliation":[{"name":"Noguchi Institute for Medical Research and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Neequaye","sequence":"additional","affiliation":[{"name":"Department of Child Health, Medical School, University of Ghana, Accra, Ghana;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Biggar","sequence":"additional","affiliation":[{"name":"Institute of Health and Biotechnical Innovation, Queensland University of Technology, Brisbane, QLD, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-346X","authenticated-orcid":false,"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute, Kampala, Uganda;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-661X","authenticated-orcid":false,"given":"Corey","family":"Casper","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine, School of Medicine, University of Washington, Seattle, WA;"},{"name":"Division of Public Health Sciences and"},{"name":"Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Global Health, School of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam M.","family":"Mbulaiteye","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor G.","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-2755","authenticated-orcid":false,"given":"Edus H.","family":"Warren","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Medicine, School of Medicine, University of Washington, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"issue":"3","key":"2019111606502686300_B1","first-page":"166","article-title":"Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr Health Sci"},{"issue":"2","key":"2019111606502686300_B2","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"2019111606502686300_B3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"Magrath","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111606502686300_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910060102","article-title":"Burkitt\u2019s lymphoma and malaria","volume":"6","author":"Kafuko","year":"1970","journal-title":"Int J Cancer"},{"issue":"14","key":"2019111606502686300_B5","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1073\/pnas.92.14.6577","article-title":"Persistence of immunoglobulin heavy chain\/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men","volume":"92","author":"M\u00fcller","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3-4","key":"2019111606502686300_B6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/10428199809057539","article-title":"Insight into Burkitt\u2019s lymphoma from immunoglobulin variable region gene analysis","volume":"30","author":"Chapman","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111606502686300_B7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","article-title":"Analysis of VH genes used by neoplastic B cells in endemic Burkitt\u2019s lymphoma shows somatic hypermutation and intraclonal heterogeneity","volume":"85","author":"Chapman","year":"1995","journal-title":"Blood"},{"issue":"3","key":"2019111606502686300_B8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2019111606502686300_B9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03401587","article-title":"Burkitt\u2019s lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes","volume":"1","author":"Klein","year":"1995","journal-title":"Mol Med"},{"issue":"5","key":"2019111606502686300_B10","first-page":"1398","article-title":"Burkitt\u2019s lymphomas express VH genes with a moderate number of antigen-selected somatic mutations","volume":"147","author":"Tamaru","year":"1995","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111606502686300_B11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0198-8859(02)00740-1","article-title":"Diversity and somatic hypermutation of the Ig VHDJH, V kappa J kappa, and V lambda J lambda gene segments in lymphoma B cells: relevance to the origin of the neoplastic B cell clone","volume":"64","author":"Riboldi","year":"2003","journal-title":"Hum Immunol"},{"issue":"17","key":"2019111606502686300_B12","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-13-3231","article-title":"Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH","volume":"20","author":"Wu","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111606502686300_B13","doi-asserted-by":"crossref","first-page":"e0160853","DOI":"10.1371\/journal.pone.0160853","article-title":"A public database of memory and naive B-cell receptor sequences","volume":"11","author":"DeWitt","year":"2016","journal-title":"PLoS One"},{"key":"2019111606502686300_B14","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/ncomms3680","article-title":"Using synthetic templates to design an unbiased multiplex PCR assay","volume":"4","author":"Carlson","year":"2013","journal-title":"Nat Commun"},{"key":"2019111606502686300_B15","first-page":"W503","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume-title":"Nucleic Acid Res","author":"Brochet","year":"2008"},{"issue":"6","key":"2019111606502686300_B16","first-page":"695","article-title":"IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harb Protoc"},{"issue":"5","key":"2019111606502686300_B17","doi-asserted-by":"crossref","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight"},{"key":"2019111606502686300_B18","first-page":"W34","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume-title":"Nucleic Acid Res","author":"Ye","year":"2013"},{"key":"2019111606502686300_B19","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume-title":"Curr Protoc Bioinformatics","author":"Van der Auwera","year":"2013"},{"issue":"8","key":"2019111606502686300_B20","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2019111606502686300_B21","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2019111606502686300_B22","unstructured":"Bertucci\n              CRM\n            \n          . Bone marrow from healthy adults. Available at: https:\/\/clients.adaptivebiotech.com\/pub\/bone-marrow-healthy-adults-control. Accessed January 27, 2017."},{"issue":"6","key":"2019111606502686300_B23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/j.1460-2075.1984.tb01955.x","article-title":"Ordered rearrangement of immunoglobulin heavy chain variable region segments","volume":"3","author":"Alt","year":"1984","journal-title":"EMBO J"},{"issue":"1","key":"2019111606502686300_B24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcp\/aqv011","article-title":"Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic Burkitt lymphoma suggests antigen drive activation of BCR as opposed to sporadic Burkitt lymphoma","volume":"145","author":"Amato","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"7418","key":"2019111606502686300_B25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2019111606502686300_B26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.leukres.2014.01.001","article-title":"Analysis of the IGHV region in Burkitt\u2019s lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis","volume":"38","author":"Baptista","year":"2014","journal-title":"Leuk Res"},{"issue":"10","key":"2019111606502686300_B27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1084\/jem.20150585","article-title":"Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome","volume":"212","author":"Kolhatkar","year":"2015","journal-title":"J Exp Med"},{"issue":"12","key":"2019111606502686300_B28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"issue":"10","key":"2019111606502686300_B29","doi-asserted-by":"crossref","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic Burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog"},{"issue":"12","key":"2019111606502686300_B30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"2019111606502686300_B31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04064.x","article-title":"Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt\u2019s lymphoma and mucosa-associated lymphoid tissue lymphoma","volume":"120","author":"Zhu","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111606502686300_B32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404467","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"van Krieken","year":"2007","journal-title":"Leukemia"},{"key":"2019111606502686300_B33","unstructured":"EuroClonality. Available at: www.euroclonality.org\/faq\/. Accessed 8 March 2017."},{"issue":"1","key":"2019111606502686300_B34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80592-0","article-title":"Somatic hypermutation in the heavy chain locus correlates with transcription","volume":"9","author":"Fukita","year":"1998","journal-title":"Immunity"},{"issue":"22","key":"2019111606502686300_B35","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1182\/blood-2012-05-429811","article-title":"Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia","volume":"120","author":"Gawad","year":"2012","journal-title":"Blood"},{"key":"2019111606502686300_B36","first-page":"319","article-title":"Burkitt\u2019s lymphoma cells frequently carry monoallelic DJ rearrangements","volume":"182","author":"Bhatia","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"2019111606502686300_B37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","article-title":"Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma","volume":"162","author":"Robbiani","year":"2015","journal-title":"Cell"},{"issue":"6","key":"2019111606502686300_B38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"issue":"14","key":"2019111606502686300_B39","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2012-02-412791","article-title":"IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas","volume":"120","author":"Greisman","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111606502686300_B40","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1084\/jem.20081007","article-title":"AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development","volume":"205","author":"Takizawa","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"2019111606502686300_B41","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ni.3160","article-title":"Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia","volume":"16","author":"Swaminathan","year":"2015","journal-title":"Nat Immunol"},{"issue":"19","key":"2019111606502686300_B42","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"issue":"7415","key":"2019111606502686300_B43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"D\u00fchren-von Minden","year":"2012","journal-title":"Nature"},{"issue":"23","key":"2019111606502686300_B44","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood-2012-08-447904","article-title":"Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells","volume":"121","author":"Zwick","year":"2013","journal-title":"Blood"},{"issue":"17","key":"2019111606502686300_B45","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2009-01-197822","article-title":"Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells","volume":"114","author":"Seiler","year":"2009","journal-title":"Blood"},{"issue":"13","key":"2019111606502686300_B46","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111606502686300_B47","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111606502686300_B48","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","article-title":"Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma","volume":"95","author":"Zibellini","year":"2010","journal-title":"Haematologica"},{"issue":"43","key":"2019111606502686300_B49","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111606502686300_B50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1084\/jem.20061923","article-title":"Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors","volume":"204","author":"Horikawa","year":"2007","journal-title":"J Exp Med"},{"issue":"4","key":"2019111606502686300_B51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20062024","article-title":"IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha\/beta","volume":"204","author":"Waisman","year":"2007","journal-title":"J Exp Med"},{"issue":"7277","key":"2019111606502686300_B52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"1","key":"2019111606502686300_B53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J Exp Med"},{"issue":"20","key":"2019111606502686300_B54","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2019111606502686300_B55","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","article-title":"PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma","volume":"370","author":"Gopal","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111606502686300_B56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/9\/535\/878301\/advances000794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/9\/535\/878301\/advances000794.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T06:50:58Z","timestamp":1573887058000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/9\/535\/15609\/Highthroughput-sequencing-of-the-Bcell-receptor-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2016000794","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}